Deletion of the androgen receptor in adipose tissue in male mice elevates retinol binding protein 4 and reveals independent effects on visceral fat mass and on glucose homeostasis

Diabetes

Volumn 61, Issue 5, 2012, Pages 1072-1081

  McInnes, Kerry J ^a   Smith, Lee B ^a   Hunger, Nicole I ^a   Saunders, Philippa T K ^a   Andrew, Ruth ^a   Walker, Brian R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; GLUCOSE; INSULIN; RETINOL BINDING PROTEIN 4;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL;

ADIPOKINES; ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; DIETARY FATS; GLUCOSE; GLUCOSE INTOLERANCE; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, ANDROGEN; RETINOL-BINDING PROTEINS, PLASMA; SIGNAL TRANSDUCTION; TESTOSTERONE;

EID: 84860548566     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-1136     Document Type: Article

References (45)

1. Kapoor D, Malkin CJ, Channer KS, Jones TH. Androgens, insulin resistance and vascular disease in men. Clin Endocrinol (Oxf) 2005;63:239-250 (Pubitemid 41233438)
2. Grossmann M, Gianatti EJ, Zajac JD. Testosterone and type 2 diabetes. Curr Opin Endocrinol Diabetes Obes 2010;17:247-256
3. Barrett-Connor E. Lower endogenous androgen levels and dyslipidmia in men with non-insulin-dependent diabetes mellitus. Ann Intern Med 1992; 117:807-811
4. Kapoor D, Goodwin E, Channer KS, Jones TH. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol 2006;154:899-906 (Pubitemid 43997730)
5. Hamilton EJ, Gianatti E, Strauss BJ, et al. Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy. Clin Endocrinol (Oxf) 2011;74:377-383
6. Jones TH. Testosterone deficiency: a risk factor for cardiovascular disease? Trends Endocrinol Metab 2010;21:496-503
7. Joyner J, Hutley L, Cameron D. Intrinsic regional differences in androgen receptors and dihydrotestosterone metabolism in human preadipocytes. Horm Metab Res 2002;34:223-228 (Pubitemid 34666583)
8. Singh R, Artaza JN, Taylor WE, et al. Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors. Endocrinology 2006;147:141-154
9. Movérare-Skrtic S, Venken K, Andersson N, et al. Dihydrotestosterone treatment results in obesity and altered lipid metabolism in orchidectomized mice. Obesity (Silver Spring) 2006;14:662-672 (Pubitemid 46219741)
10. Sato T, Matsumoto T, Yamada T, Watanabe T, Kawano H, Kato S. Late onset of obesity in male androgen receptor-deficient (AR KO) mice. Biochem Biophys Res Commun 2003;300:167-171 (Pubitemid 36042946)
11. Fan WQ, Yanase T, Nomura M, et al. Androgen receptor null male mice develop late-onset obesity caused by decreased energy expenditure and lipolytic activity but show normal insulin sensitivity with high adiponectin secretion. Diabetes 2005;54:1000-1008 (Pubitemid 40450323)
12. Yu IC, Lin HY, Liu NC, et al. Hyperleptinemia without obesity in male mice lacking androgen receptor in adipose tissue. Endocrinology 2008;149: 2361-2368
13. Lin HY, Yu IC, Wang RS, et al. Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor. Hepatology 2008;47: 1924-1935
14. Eguchi J, Wang X, Yu ST, et al. Transcriptional control of adipose lipid handling by IRF4. Cell Metab 2011;13:249-259
15. De Gendt K, Swinnen JV, Saunders PTK, et al. A Sertoli cell-selective knockout of the androgen receptor causes spermatogenic arrest in meiosis. Proc Natl Acad Sci U S A 2004;101:1327-1332 (Pubitemid 38182688)
16. Welsh M, Saunders PTK, Atanassova N, Sharpe RM, Smith LB. Androgen action via testicular peritubular myoid cells is essential for male fertility. FASEB J 2009;23:4218-4230
17. Morton NM, Holmes MC, Fiévet C, et al. Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice. J Biol Chem 2001;276: 41293-41300
18. Winzell MS, Ahrén B. The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes 2004;53(Suppl. 3):S215-S219 (Pubitemid 39564546)
19. Corker CS, Davidson DW. A radioimmunoassay for testosterone in various biological fluids without chromatography. J Steroid Biochem 1978;9:373-374 (Pubitemid 8349061)
20. Yang Q, Graham TE, Mody N, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005; 436:356-362 (Pubitemid 41065039)
21. De Sousa Peixoto RA, Turban S, Battle JH, Chapman KE, Seckl JR, Morton NM. Preadipocyte 11beta-hydroxysteroid dehydrogenase type 1 is a ketoreductase and contributes to diet-induced visceral obesity in vivo. Endocrinology 2008;149:1861-1868 (Pubitemid 351468317)
22. McInnes KJ, Corbould A, Simpson ER, Jones ME. Regulation of adenosine 5′, monophosphate-activated protein kinase and lipogenesis by androgens contributes to visceral obesity in an estrogen-deficient state. Endocrinology 2006;147:5907-5913 (Pubitemid 44833508)
23. Zitzmann M, Faber S, Nieschlag E. Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 2006;91:4335-4343 (Pubitemid 44833407)
24. Bojesen A, Kristensen K, Birkebaek NH, et al. The metabolic syndrome is frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism. Diabetes Care 2006;29:1591-1598 (Pubitemid 44127586)
25. Basaria S, Muller DC, Carducci MA, Egan J, Dobs AS. Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy. Cancer 2006;106:581-588 (Pubitemid 43157621)
26. Zitzmann M, Gromoll J, von Eckardstein A, Nieschlag E. The CAG repeat polymorphism in the androgen receptor gene modulates body fat mass and serum concentrations of leptin and insulin in men. Diabetologia 2003; 46:31-39 (Pubitemid 36237744)
27. Lin HY, Xu QQ, Yeh SY, Wang RS, Sparks JD, Chang CS. Insulin and leptin resistance with hyperleptinemia in mice lacking androgen receptor. Diabetes 2005;54:1717-1725 (Pubitemid 40770762)
28. Kobayashi K. Adipokines: therapeutic targets for metabolic syndrome. Curr Drug Targets 2005;6:525-529 (Pubitemid 40916277)
29. Hotta K, Funahashi T, Bodkin NL, et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 2001;50:1126-1133 (Pubitemid 32374544)
30. Yatagai T, Nagasaka S, Taniguchi A, et al. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism 2003;52:1274-1278 (Pubitemid 37351094)
31. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996;271:10697-10703 (Pubitemid 26145805)
32. Blüher M, Michael MD, Peroni OD, et al. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev Cell 2002;3:25-38 (Pubitemid 34778393)
33. Semple RK, Soos MA, Luan J, et al. Elevated plasma adiponectin in humans with genetically defective insulin receptors. J Clin Endocrinol Metab 2006;91:3219-3223 (Pubitemid 44271779)
34. Lanfranco F, Zitzmann M, Simoni M, Nieschlag E. Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy. Clin Endocrinol (Oxf) 2004;60:500-507 (Pubitemid 38482514)
35. Graham TE, Yang Q, Mody N, et al. Serum retinol binding protein (RBP4) is a novel adipocyte-secreted protein elevated in obesity and type 2 diabetes that contributes to insulin resistance. Diabetes 2005; 54:A5
36. Cho YM, Youn BS, Lee H, et al. Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care 2006;29:2457-2461 (Pubitemid 44912252)
37. Klöting N, Graham TE, Berndt J, et al. Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. Cell Metab 2007;6: 79-87 (Pubitemid 46995778)
38. Graham TE, Klöting N, Berndt J, et al. Serum retinal binding protein (RBP4) levels predict intraabdominal fat mass. Diabetes 2007;56:A365
39. Tan BK, Chen J, Lehnert H, Kennedy R, Randeva HS. Raised serum, adipocyte, and adipose tissue retinol-binding protein 4 in overweight women with polycystic ovary syndrome: effects of gonadal and adrenal steroids. J Clin Endocrinol Metab 2007;92:2764-2772 (Pubitemid 47037388)
40. Ost A, Danielsson A, Lidén M, Eriksson U, Nystrom FH, Strålfors P. Retinol-binding protein-4 attenuates insulin-induced phosphorylation of IRS1 and ERK1/2 in primary human adipocytes. FASEB J 2007;21:3696-3704 (Pubitemid 350075157)
41. Danielsson A, Ost A, Lystedt E, et al. Insulin resistance in human adipocytes occurs downstream of IRS1 after surgical cell isolation but at the level of phosphorylation of IRS1 in type 2 diabetes. FEBS J 2005;272:141-151 (Pubitemid 40083074)
42. Wu Y, Li HX, Loos RJF, et al. RBP4 variants are significantly associated with plasma RBP4 levels and hypertriglyceridemia risk in Chinese Hans. J Lipid Res 2009;50:1479-1486
43. Graham TE, Yang Q, Blüher M, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006;354: 2552-2563 (Pubitemid 43882351)
44. Takebayashi K, Suetsugu M, Wakabayashi S, Aso Y, Inukai T. Retinol binding protein-4 levels and clinical features of type 2 diabetes patients. J Clin Endocrinol Metab 2007;92:2712-2719 (Pubitemid 47037380)
45. Lee DC, Lee JW, Im JA. Association of serum retinol binding protein 4 and insulin resistance in apparently healthy adolescents. Metabolism 2007;56: 327-331